← All organizations

Criterium, Inc.

For profitWebsite ↗

Also known as: Criterium, Inc. | Criterium Inc., d.b.a. Academic GI Cancer Consortium (AGICC)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 15, 2025

Timeline

1990s

Jun 1, 1991
Criterium, Inc.— Founded

Drugs by trial phase (27 distinct, 15 trials)

Phase 2 (27 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06992258Lead sponsorPhase 2Sep 15, 2025
NCT05458674Lead sponsorPhase 2Nov 15, 2022
NCT05230810Lead sponsorPhase 1/Phase 2Aug 25, 2022
NCT05167409CollaboratorPhase 2Jul 14, 2022
NCT05180422Lead sponsorPhase 1/Phase 2Jun 15, 2022
NCT04739358Lead sponsorPhase 1/Phase 2Jul 2, 2021
NCT04963283CollaboratorPhase 2Jun 23, 2021
NCT04791384Lead sponsorPhase 1/Phase 2May 31, 2021
NCT04567420Lead sponsorPhase 2Dec 15, 2020
NCT04169347Lead sponsorPhase 2Dec 31, 2019
NCT02706626Lead sponsorPhase 2Mar 9, 2017
NCT02723331CollaboratorPhase 2Dec 30, 2016
NCT02638909Overall official - principal investigatorPhase 2Dec 1, 2015
NCT02638909Lead sponsorPhase 2Dec 1, 2015
NCT01789242CollaboratorPhase 1Feb 1, 2013

Details

Founded: Pennington, NJ, US Jun 1, 1991
Last known activity: Sep 15, 2025

Notes

CRO